Clinical Trials Logo

Rheumatoid Arthritis clinical trials

View clinical trials related to Rheumatoid Arthritis.

Filter by:

NCT ID: NCT02424877 Completed - Clinical trials for Rheumatoid Arthritis

Cell Phone Based Automated Monitoring of Patients With Early Rheumatoid Arthritis

SandRA
Start date: August 1, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether automated remote monitoring of patients with early rheumatoid arthritis by the SandRA software and short message service of cell phones increases patient compliance and helps to identify patients needing re-assessment of medication before scheduled visits. This might result in better clinical outcome and cost-effectiveness.

NCT ID: NCT02410304 Completed - Clinical trials for Rheumatoid Arthritis

Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment

BCD
Start date: October 6, 2015
Phase: N/A
Study type: Interventional

This study compares different methods of clinical evaluation (C) and/or ultrasound (B or D) concerning the rheumatoid arthritis in order to monitore the treatment. This study will provide the exact number of patients in remission according the 3 methods. It could allow to assess the concordance between the 3 evaluated methods. This study will permit to define the best method which limit the evolution of structural damages ( principal criteria).

NCT ID: NCT02404558 Completed - Clinical trials for Rheumatoid Arthritis

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Start date: May 2015
Phase: Phase 1
Study type: Interventional

Primary Objective: To describe the safety and tolerability, including laboratory abnormalities following a single dose of sarilumab or tocilizumab administered subcutaneously (SC) as monotherapy in Japanese patients with rheumatoid arthritis (RA). Secondary Objectives: To describe the laboratory abnormalities (absolute neutrophil count [ANC], platelet counts, total cholesterol, high-density lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, and liver function tests [LFTs]) following a single dose of sarilumab or tocilizumab administered SC as monotherapy in Japanese patients with RA. To describe the pharmacokinetics (PK) of sarilumab and tocilizumab.

NCT ID: NCT02402686 Completed - Clinical trials for Rheumatoid Arthritis

Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)

SIMPACT
Start date: May 20, 2015
Phase:
Study type: Observational

The aim of this non-interventional study in Hungarian participants is to gather real life data about the efficacy and safety of tocilizumab SC monotherapy in RA, to assess data about pattern of usage of tocilizumab monotherapy in RA disease management.

NCT ID: NCT02401958 Completed - Clinical trials for Rheumatoid Arthritis

Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis

Start date: March 2014
Phase: Phase 4
Study type: Interventional

ABSTRACT Introduction: Rheumatoid arthritis (RA) is a systemic inflammatory, chronic and progressive disease that can lead to joint destruction and important functional disability. Chronic inflammation, with a substantial increase in the amount of pro-inflammatory cytokines in synovial joint, is one of the biggest challenges in controlling RA. Resistance exercise has been recognized for positively modulate inflammation in healthy subjects. Objective: To evaluate the effect of an acute bout of resistance exercise on serum concentrations of tumor necrosis factor alpha (TNF-α), interleukin 1 receptor antagonist(IL-1ra), interleukin 1 beta (IL-1β), C reactive protein (CRP), interleukin 6 (IL-6), interleukin 10 (IL-10), and cartilage oligomeric matrix protein (COMP) in postmenopausal women with RA and women without the disease. Methods: 17 volunteers with RA and 17 without the disease, with a mean age of 54.7 + 6.63 underwent a resistance exercise session with a set of 12 repetitions at 50% of one repetition maximum (1RM ) and a set of 8 repetitions at 75% of 1RM. The exercises performed were: knee extension, knee flexion, hip abduction and hip adduction. Blood samples were obtained 30 minutes before, 5 minutes before, immediately after, 1 hour, 2 hours and 24 hours after the exercise session. Serum glucose concentrations prior to exercise were also measured. The investigators used the Student's't test, the model of analysis of variance with repeated measures and Bonferroni method of multiple comparisons to analyze the data, being considered statistically significant levels of p <0.05.

NCT ID: NCT02401165 Completed - Clinical trials for Rheumatoid Arthritis

Quantification of GADD34 Expression in RA

GADD34-RA
Start date: March 2013
Phase: N/A
Study type: Interventional

GADD34 is an inducible cofactor of protein phosphatase 1, which has an important role in the Unfolded Protein Response (UPR). UPR is a cellular response to ER stress which is implicated in several autoimmune diseases. GADD34 has been shown to be necessary for proinflammatory cytokine production in response to viral infection in murine models. Nevertheless, the role of GADD34 in cytokine production in humans remains to be elucidated. Here, we investigate the interest of GADD34 in rheumatoid arthritis (RA), in which proinflammatory cytokines have an important pathogenic role. A case-control study on GADD34 gene expression in PBMC of patients (n=75) with RA and age- and sex-matched healthy controls (n=25). GADD34 gene expression levels in PBMC were measured by quantitative PCR.

NCT ID: NCT02399007 Completed - Clinical trials for Rheumatoid Arthritis

A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China

Start date: June 7, 2015
Phase: N/A
Study type: Interventional

A clinical trial of total Hip system used in Primary Total Hip Arthroplasty in China.

NCT ID: NCT02397798 Completed - Clinical trials for Rheumatoid Arthritis

Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether person-centered high-intense aerobic / strength training during five months reduces inflammation and disease activity, improve immune cell function, and increases muscle strength, fitness and ability of the individual independence in elderly patients with rheumatoid arthritis.

NCT ID: NCT02387762 Completed - Clinical trials for Rheumatoid Arthritis

ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

Start date: April 2015
Phase: Phase 2
Study type: Interventional

This study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of ACP-196 in subjects with Rheumatoid Arthritis on background Methotrexate.

NCT ID: NCT02382783 Completed - Clinical trials for Rheumatoid Arthritis

Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).